Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

BIO-FLARE collaboration explores biological factors that trigger flares in rheumatoid arthritis

March 17, 2017

Pfizer patents IRAK-4 inhibitors

March 14, 2017

Kevzara becomes available in Canada

March 1, 2017

Pfizer describes novel IRAK-4 inhibitors

Feb. 27, 2017

Novel IRAK-4 inhibitors discovered at Beijing Hanmi Pharmaceutical

Feb. 24, 2017

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

Merck KGaA compares MSB-11022 to Humira in phase III trial for rheumatoid arthritis

Feb. 21, 2017

Taiho Pharmaceutical discovers JAK3 inhibitors

Feb. 16, 2017

European Commission approves Olumiant for rheumatoid arthritis

Feb. 14, 2017

Can-Fite Biopharma set to begin phase III ACRobat study of piclidenoson

Feb. 9, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...